Rennova Health Past Earnings Performance

Past criteria checks 2/6

Rennova Health's earnings have been declining at an average annual rate of -9.3%, while the Healthcare industry saw earnings growing at 7% annually. Revenues have been declining at an average rate of 3.5% per year.

Key information

-9.3%

Earnings growth rate

n/a

EPS growth rate

Healthcare Industry Growth8.5%
Revenue growth rate-3.5%
Return on equityn/a
Net Margin11.7%
Last Earnings Update30 Sep 2023

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Rennova Health makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:RNVA Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2320290
30 Jun 2320280
31 Mar 2317-19580
31 Dec 2213-33470
30 Sep 2210-43360
30 Jun 228-69160
31 Mar 225-59660
31 Dec 213-51280
30 Sep 213-618100
30 Jun 214-429110
31 Mar 215-329120
31 Dec 207-281120
30 Sep 209-85120
30 Jun 2011-27120
31 Mar 2013-39140
31 Dec 1916-170160
30 Sep 1918-385170
30 Jun 1919-294180
31 Mar 1918-235170
31 Dec 1815-245150
30 Sep 1811-44150
30 Jun 187-136150
31 Mar 184-195160
31 Dec 173-104170
30 Sep 171-85100
30 Jun 170-84160
31 Mar 172-7518-1
31 Dec 163-23210
30 Sep 16-6-51290
30 Jun 16-1-41250
31 Mar 167-42311
31 Dec 1518-38310
30 Sep 1541-11350
30 Jun 1558-7400
31 Mar 15700400
31 Dec 14773440
30 Sep 148411410
30 Jun 147810380
31 Mar 14669330
31 Dec 13536270
30 Sep 13425240
30 Jun 13344200

Quality Earnings: RNVA has a large one-off gain of $968.2K impacting its last 12 months of financial results to 30th September, 2023.

Growing Profit Margin: RNVA became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: RNVA has become profitable over the past 5 years, growing earnings by -9.3% per year.

Accelerating Growth: RNVA has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: RNVA has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (9.2%).


Return on Equity

High ROE: RNVA's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.